Study Hints at Late-Life Cognitive Effects of Childhood Epilepsy

SAN DIEGO—Age-accelerated changes in certain aspects of cognition, including psychomotor speed and verbal memory, appear to occur in aging persons with childhood-onset epilepsy, compared with healthy controls, according to preliminary results from an ongoing study.

“One thing that remains unclear is how people with childhood-onset epilepsies age over the decades in terms of brain structure and function,” said Bruce Hermann, PhD, at the 66th Annual Meeting of the American Epilepsy Society. “There has been much interest in the issues of cognitive and brain aging in the general population, and, of course, in disorders such as dementia and Alzheimer’s disease, but unknown is how individuals with childhood-onset epilepsy may age over the decades. There are very few population-based cohorts available to address that question.”

Dr. Hermann, Director of the Charles Matthew Neuropsychology Section of the Department of Neurology at the University of Wisconsin, Madison, is examining this question in collaboration with Matti Sillanpää, MD, PhD, Professor Emeritus of Child Neurology at the University of Turku in Finland.

Together they are studying Dr. Sillanpää’s well-known population-based cohort of children with epilepsy and controls. Followed since their youth over the decades, the research participants now range in age from 45 to 62 years.

These subjects are returning for a comprehensive battery of cognitive tests, neuroimaging, EEG, and clinical interviews to evaluate their aging processes. Cognitive tests administered include the Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog), the Wechsler Adult Intelligence Scale–III (WAIS-III), the Boston Naming Test, the Controlled Oral Word Association Test, the Clock Drawing Test, the Wechsler Memory Scale–Revised (WMS-R), the Rey Auditory Verbal Learning Test, the Trail Making Test, and the Beck Depression Inventory. The follow-up visits also include structural MRI and PET amyloid and glucose imaging.

The mean age of patients examined to date is 57, and they are compared with a group of similarly aged matched controls. Dr. Hermann reported that in the first group of participants to be examined, 26 epilepsy patients performed significantly worse than did 31 controls on measures of psychomotor speed, based on the WAIS-III, and in delayed verbal memory, based on the WMS-R.

“Secondary analyses revealed that patients with persisting abnormal EEG and either active epilepsy or seizures into adulthood had more adversely affected cognition, compared to those whose epilepsy completely remitted,” the researchers noted.

Results from the PET imaging studies are pending, Dr. Hermann said, but preliminary results from the MRI studies demonstrated that there were no differences in cortical thickness between the epilepsy and control groups after correction for multiple comparisons and adjustment for age and gender. However, compared with the control group, the epilepsy group demonstrated a significant increase in the white matter hypointensity index and a trend toward larger left and right lateral ventricles.

“What’s surprising is that their MRI results look as good as they do, compared with controls,” Dr. Hermann said. “We thought we’d see more pathology and age-accelerated changes.”

Dr. Sillanpää’s entire cohort is in the process of returning for follow-up, and the results should shed new light on the issues of cognitive and brain aging in childhood epilepsy.

SAN DIEGO—Age-accelerated changes in certain aspects of cognition, including psychomotor speed and verbal memory, appear to occur in aging persons with childhood-onset epilepsy, compared with healthy controls, according to preliminary results from an ongoing study.

“One thing that remains unclear is how people with childhood-onset epilepsies age over the decades in terms of brain structure and function,” said Bruce Hermann, PhD, at the 66th Annual Meeting of the American Epilepsy Society. “There has been much interest in the issues of cognitive and brain aging in the general population, and, of course, in disorders such as dementia and Alzheimer’s disease, but unknown is how individuals with childhood-onset epilepsy may age over the decades. There are very few population-based cohorts available to address that question.”

Dr. Hermann, Director of the Charles Matthew Neuropsychology Section of the Department of Neurology at the University of Wisconsin, Madison, is examining this question in collaboration with Matti Sillanpää, MD, PhD, Professor Emeritus of Child Neurology at the University of Turku in Finland.

Together they are studying Dr. Sillanpää’s well-known population-based cohort of children with epilepsy and controls. Followed since their youth over the decades, the research participants now range in age from 45 to 62 years.

These subjects are returning for a comprehensive battery of cognitive tests, neuroimaging, EEG, and clinical interviews to evaluate their aging processes. Cognitive tests administered include the Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog), the Wechsler Adult Intelligence Scale–III (WAIS-III), the Boston Naming Test, the Controlled Oral Word Association Test, the Clock Drawing Test, the Wechsler Memory Scale–Revised (WMS-R), the Rey Auditory Verbal Learning Test, the Trail Making Test, and the Beck Depression Inventory. The follow-up visits also include structural MRI and PET amyloid and glucose imaging.

The mean age of patients examined to date is 57, and they are compared with a group of similarly aged matched controls. Dr. Hermann reported that in the first group of participants to be examined, 26 epilepsy patients performed significantly worse than did 31 controls on measures of psychomotor speed, based on the WAIS-III, and in delayed verbal memory, based on the WMS-R.

“Secondary analyses revealed that patients with persisting abnormal EEG and either active epilepsy or seizures into adulthood had more adversely affected cognition, compared to those whose epilepsy completely remitted,” the researchers noted.

Results from the PET imaging studies are pending, Dr. Hermann said, but preliminary results from the MRI studies demonstrated that there were no differences in cortical thickness between the epilepsy and control groups after correction for multiple comparisons and adjustment for age and gender. However, compared with the control group, the epilepsy group demonstrated a significant increase in the white matter hypointensity index and a trend toward larger left and right lateral ventricles.

“What’s surprising is that their MRI results look as good as they do, compared with controls,” Dr. Hermann said. “We thought we’d see more pathology and age-accelerated changes.”

Dr. Sillanpää’s entire cohort is in the process of returning for follow-up, and the results should shed new light on the issues of cognitive and brain aging in childhood epilepsy.

SAN DIEGO—Age-accelerated changes in certain aspects of cognition, including psychomotor speed and verbal memory, appear to occur in aging persons with childhood-onset epilepsy, compared with healthy controls, according to preliminary results from an ongoing study.

“One thing that remains unclear is how people with childhood-onset epilepsies age over the decades in terms of brain structure and function,” said Bruce Hermann, PhD, at the 66th Annual Meeting of the American Epilepsy Society. “There has been much interest in the issues of cognitive and brain aging in the general population, and, of course, in disorders such as dementia and Alzheimer’s disease, but unknown is how individuals with childhood-onset epilepsy may age over the decades. There are very few population-based cohorts available to address that question.”

Dr. Hermann, Director of the Charles Matthew Neuropsychology Section of the Department of Neurology at the University of Wisconsin, Madison, is examining this question in collaboration with Matti Sillanpää, MD, PhD, Professor Emeritus of Child Neurology at the University of Turku in Finland.

Together they are studying Dr. Sillanpää’s well-known population-based cohort of children with epilepsy and controls. Followed since their youth over the decades, the research participants now range in age from 45 to 62 years.

These subjects are returning for a comprehensive battery of cognitive tests, neuroimaging, EEG, and clinical interviews to evaluate their aging processes. Cognitive tests administered include the Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog), the Wechsler Adult Intelligence Scale–III (WAIS-III), the Boston Naming Test, the Controlled Oral Word Association Test, the Clock Drawing Test, the Wechsler Memory Scale–Revised (WMS-R), the Rey Auditory Verbal Learning Test, the Trail Making Test, and the Beck Depression Inventory. The follow-up visits also include structural MRI and PET amyloid and glucose imaging.

The mean age of patients examined to date is 57, and they are compared with a group of similarly aged matched controls. Dr. Hermann reported that in the first group of participants to be examined, 26 epilepsy patients performed significantly worse than did 31 controls on measures of psychomotor speed, based on the WAIS-III, and in delayed verbal memory, based on the WMS-R.

“Secondary analyses revealed that patients with persisting abnormal EEG and either active epilepsy or seizures into adulthood had more adversely affected cognition, compared to those whose epilepsy completely remitted,” the researchers noted.

Results from the PET imaging studies are pending, Dr. Hermann said, but preliminary results from the MRI studies demonstrated that there were no differences in cortical thickness between the epilepsy and control groups after correction for multiple comparisons and adjustment for age and gender. However, compared with the control group, the epilepsy group demonstrated a significant increase in the white matter hypointensity index and a trend toward larger left and right lateral ventricles.

“What’s surprising is that their MRI results look as good as they do, compared with controls,” Dr. Hermann said. “We thought we’d see more pathology and age-accelerated changes.”

Dr. Sillanpää’s entire cohort is in the process of returning for follow-up, and the results should shed new light on the issues of cognitive and brain aging in childhood epilepsy.